Correlation Between Itama Ranoraya and Diagnos Laboratorium

Can any of the company-specific risk be diversified away by investing in both Itama Ranoraya and Diagnos Laboratorium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Itama Ranoraya and Diagnos Laboratorium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Itama Ranoraya and Diagnos Laboratorium Utama, you can compare the effects of market volatilities on Itama Ranoraya and Diagnos Laboratorium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Itama Ranoraya with a short position of Diagnos Laboratorium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Itama Ranoraya and Diagnos Laboratorium.

Diversification Opportunities for Itama Ranoraya and Diagnos Laboratorium

0.8

Correlation Coefficient

Itama Ranoraya  Diagnos Laboratorium

Very poor diversification

The 3 months correlation between Itama and Diagnos is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Itama Ranoraya and Diagnos Laboratorium Utama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diagnos Laboratorium and Itama Ranoraya is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Itama Ranoraya are associated (or correlated) with Diagnos Laboratorium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diagnos Laboratorium has no effect on the direction of Itama Ranoraya i.e., Itama Ranoraya and Diagnos Laboratorium go up and down completely randomly.

Pair Corralation between Itama Ranoraya and Diagnos Laboratorium

Assuming the 90 days trading horizon Itama Ranoraya is expected to generate 0.31 times more return on investment than Diagnos Laboratorium. However, Itama Ranoraya is 3.19 times less risky than Diagnos Laboratorium. It trades about -0.22 of its potential returns per unit of risk. Diagnos Laboratorium Utama is currently generating about -0.12 per unit of risk. If you would invest  48,600  in Itama Ranoraya on September 16, 2024 and sell it today you would lose (7,200) from holding Itama Ranoraya or give up 14.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Itama Ranoraya  vs.  Diagnos Laboratorium Utama

Itama Ranoraya

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Itama Ranoraya has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Diagnos Laboratorium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diagnos Laboratorium Utama has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Itama Ranoraya and Diagnos Laboratorium

The main advantage of trading using opposite Itama Ranoraya and Diagnos Laboratorium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Itama Ranoraya position performs unexpectedly, Diagnos Laboratorium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will offset losses from the drop in Diagnos Laboratorium's long position.

The idea behind Itama Ranoraya and Diagnos Laboratorium Utama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.